Worldwide Liquid Biopsy Market, 2021 by Screening/Drug Monitoring/Diagnostic

The term liquid biopsy encompasses various diagnostic methods that use liquid, non-tissue specimens to provide information that can aid in the diagnosis, treatment and monitoring of cancer. Currently, tissue biopsies, along with imaging techniques, are the standard methods used in the diagnosis of solid cancers, but despite their widespread use, they have many limitations that open the door for other diagnostic technologies in oncology clinical settings.

The term liquid biopsy encompasses various diagnostic methods that use liquid, non-tissue specimens to provide information that can aid in the diagnosis, treatment and monitoring of cancer. Currently, tissue biopsies, along with imaging techniques, are the standard methods used in the diagnosis of solid cancers, but despite their widespread use, they have many limitations that open the door for other diagnostic technologies in oncology clinical settings.

The Worldwide Market for Liquid Biopsy Contains Markets for the Following:

Liquid Biopsy Testing Applications in Oncology include:

Key Topics Covered:

1: Executive Summary

2: Liquid Biopsy Technologies

3: Circulating Tumor Dna (Cfdna) Liquid Biopsy

4: Circulating Tumor Cells (Ctcs) Liquid Biopsy

5: Extracellular Vesicles And Other Liquid Biopsy

6: Liquid Biopsy Industry Analysis

7: Liquid Biopsy Market Size And Forecast

8: Market By Type Of Analyte

9: Market By Type Of Application

10: Market By Type Of Cancer

11: Liquid Biopsy Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/x9sk78/the_worldwide

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716